{"name":"Vyriad, Inc.","slug":"vyriad-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxOSjRYSHNzbkE2WjJUM0U5cmxwdktHblROd0hoeFlhaWd3RHBXMXdHYTFVWkl3U0ROQnBtRWZleFcwUXg0T2QycVFwUUJrRlVnNGpkQlBYdlY4bndsd2FubjJ0aUgyQ19IQUJWSWRrcGRVbUVTX3FEOUdjVFR4WUFFNmNzWmV3cHk2MTB0eDFwdmV0a09tZnRDaFBoU3pVRVdWeldrQm9nNnY3YmljSmJndE5mWjc3d0YtUjV4WmNJSE9MaVhqWFBic1NBYTVsX0kzSXBGbEFmV0lESU5ON18tU1NpMlFZanBjZkJtbTZaOHlyRTc3VVR4UVFIRUZscThDTzBPQmNtd2l1cTRfdkUyOG1DZWJTQ2N2TFhiMjRnWml6MWVjYW5GeDFydXZicC0xeVRFMVh4QzBudw?oc=5","date":"2026-03-30","type":"trial","source":"Mena FN","summary":"Urothelial Carcinoma Clinical Trial Pipeline Expands As 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market Entry, Finds Delveinsight Janssen Research And Development, Medpacto - Mena FN","headline":"Urothelial Carcinoma Clinical Trial Pipeline Expands As 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNVDhVbXdyRmlrQVl1ZVhpZTRzNVAzRlZ2MW9BX2ZBMmUyUnQxTFFVWDhaSUlNZ0Nmbm5ndXQwcDd3bmtBQkdaeGxnckVyTGIyT2FmM084VTFhWHc4ZFM1MkV6dW9wdkt6VmZSQWtxcFpHMjJ5NEJUczYtWFNNSktjOTV5TGtDdjQ3QWUtS1Qzd1dPQmc2aUQxaExaSWJXeWRzVnFMUg?oc=5","date":"2025-12-24","type":"trial","source":"bizjournals.com","summary":"Vyriad, startup from Mayo doctors, raises $25M for trial of multiple myeloma treatment - bizjournals.com","headline":"Vyriad, startup from Mayo doctors, raises $25M for trial of multiple myeloma treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPay1NMUEwRXprbXkwa1NqVy1qcXc3cERja0tOYk9HWlJ5eGNHQUg2X2Z6RV9fVlFPM1ZJVS1kLS1haVB2MEtfWW1yMWlReU5HZVVCOERDMkF5VW5aN2ROZnRLb3JYaWwtc3kyQUZON0JRNDZCd2VZZVJFVW1Ec2tJV1RHVDNsRVV5dE1IRXpoQ29wWDJCeGhZYlpIWnlWNjhmcDZwdThzUGRTazlMNWpxdEtScGltbTFOcEVlVDZiN0lZRTJTb0I2enVib2x3VGdidzRHcFY3a3JMSVZWRUdkS3dn?oc=5","date":"2025-12-23","type":"pipeline","source":"Business Wire","summary":"Vyriad Secures Final $25M Series B Tranche to Advance In Vivo CAR T Candidate into Clinic - Business Wire","headline":"Vyriad Secures Final $25M Series B Tranche to Advance In Vivo CAR T Candidate into Clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFA3Y3lrS1A1Xy1mVXVGWVNhdTgyM3lQWFIyZFBYOEtzby1Da2I0Y2RMYU43VGlNc0xETFV4a0txWjNkWm92RmVrdWthNTVmZXVpeHFiRVFuckpuRWlRLXVveFVVNmtxNUlSZ2txV2ExbGpnM1FnZWc?oc=5","date":"2025-01-08","type":"trial","source":"Oncology Pipeline","summary":"In vivo Car-T gains traction | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"In vivo Car-T gains traction | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQdXF4c2dXZ0gxNDJSVGdXa2xPWjRlbjVPcWc4bGhvUnNjalVlaWtNNWtDVGRWSEN1ZHNGbFU5RjdaUEZ6cFVuOHByOVdHdUt1Q1piVUpORW8wWmxDQ0dfUjh3RUlhWXg5dFdLMVFoeEQ5Uy1pWFhVY0R4cXZ2SVlLVmJHVlVCazVFSkFPejZGclVTNkNfUlBubC1zbnA1WmVnV2FPbTduUmVZanE0NVE1RDA5WXNTR3FKbzV3cUgzUFpFQXR1RmhVUi1QUjE4UzcxM01iMTFwYW1LQS12cmZpZjMwdTU?oc=5","date":"2024-11-20","type":"deal","source":"PR Newswire","summary":"Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies - PR Newswire","headline":"Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPVkhhc3BrQzJURTJHQmhDbEp0SnlIaHVOY3dSUE01cUxvS201emoxNTFRdm95Z1NVRVZZODNtVWlXWjc5V1VfM2l4YlZ0czhqVWFXLVRPUmhyYjVyUzVhTnF1Q1pnNWhmbHZkaXAxQ3phdE1XeWZ5ZlJhWEdObEJLMVZnN0Z1Sng1U0tzdUFJV2NpOWRSSnVaZFNHM3cwYWtfYWc?oc=5","date":"2022-05-17","type":"pipeline","source":"postbulletin.com","summary":"Rochester's Vyriad lands a new $29.5 million round of investment - postbulletin.com","headline":"Rochester's Vyriad lands a new $29.5 million round of investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOZFh3em9pRXMyUGlxa1Q2RmNFRnhra0NhYkxpLUFCMEVSa2dDM2QwaGhYSEVKRVFacU9MRWdLampjY21mWXN0aTdSNHVHdFRnUl9DNWJlT2F5Wnc5SzZYeGR3aUZwSG1xaWdpaUUwbXNidXpZZjc4OGRhaDFHZk9HOFZRRF9mSUQ0Y0k0b2pqMV9PQnJVZUhUaVFYRFFVaDRPN0l5cld2UndMY3ZEOVhwbEhYalZZajNDeEFjajBCdkVma29NQ2R5NXdzZjlYcUZtRmx3?oc=5","date":"2022-05-17","type":"pipeline","source":"PR Newswire","summary":"Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur - PR Newswire","headline":"Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxONzhqNmxRd1RKWFZ2cjVwLXRvdGZENnNQeU1jemtPSGFNczZLVW1lUkFRcUZLcUxDcS1uckh1Qkwwd01CYnJteFFVVHVSRTEzdngxZHFrTWh6S2tRWFNxenlPaDhoRWlXV0FRRVhuWTE3SnVpUWtncmJiY2J6dlM2cnU5ZFpfdjBSSHI1aXl5Wm1fTHhaQ1J1VDVTUjJyNU9YeFJlYjRRbF8wUHhH?oc=5","date":"2019-11-22","type":"pipeline","source":"bizjournals.com","summary":"Cancer-killing virus designer Vyriad raises $24.4 million - bizjournals.com","headline":"Cancer-killing virus designer Vyriad raises $24.4 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQWkRTamhCUlpPeDBzVHprdGxNRmlhLWhWRWRkQzI3SFlIMU1fcllGV3lmRlFvWVRhLWNGWVpIN1c4NXQwNU01ZHBnbGNtazFJZS0tQWpsUG1EaVJMYWVRZ2diZVNlYjZKbDhSM1M0dUZ0NERvRFZBTlAxQlBsTU1WS3hXVzRld2hTYU9QMHBHMA?oc=5","date":"2017-04-12","type":"pipeline","source":"Twin Cities Business","summary":"Rochester Startup Vyriad Expanding, Signs Lease For Ex-IBM Building - Twin Cities Business","headline":"Rochester Startup Vyriad Expanding, Signs Lease For Ex-IBM Building","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}